February 1, 2022
Cytognos divestment is a first strategic step aimed at positioning Vitro as a new worldwide diagnostic player in their key market segments SEVILLE, Spain -- Vitro S.A, (www.vitro.bio) a privately held company headquartered in Seville, Spain, announced today the sale of Cytognos to Becton Dickinson and Company (BD). Cytognos is a company specializing in flow cytometry solutions for blood [...]
Institut Paoli Calmettes Extends Partnership with SOPHiA GENETICS
February 1, 2022
BOSTON, LAUSANNE, BORDEAUX, and MARSEILLE – SOPHiA GENETICS (Nasdaq: SOPH), a leader in Data-Driven Medicine, have announced, in conjunction with Assises de Génétique, an extension of their partnership with Institut Paoli Calmettes (IPC), one of the 18 French Comprehensive Cancer Centers (CLCC), to further support the implementation, automatization, and accreditation of solid tumor tests, to include [...]
NEOGEN Launches K-Blue® Luminescent Substrate
February 1, 2022
LEXINGTON, Ky. — NEOGEN Corporation (NASDAQ: NEOG) announced today that it has added a new chemiluminescent substrate as part of the trusted K-Blue® product line. K-Blue Luminescent is a two-component, luminol-based substrate that offers high sensitivity, ranging from the nanogram down to the femtogram level. This new formula is optimized to emit maximum light at [...]
February 1, 2022
BUFFALO, N.Y. -- Purity Scientific LLC, a parent company of GenTech Scientific which is a leading provider and servicer of refurbished scientific instruments, announced that it has acquired Conquer Scientific. The acquisition combined two industry leaders, allowing us to be number one in the world with a robust service network, unmatched resources, and an unparalleled inventory of [...]
February 1, 2022
Small to mid-sized enterprises and academic medical centers will have access to scalable and flexible solutions Cytiva, a global life sciences leader, and NecstGen, aim to accelerate the development of new cell and gene therapies globally via a strategic collaboration. Cytiva will provide its technologies, services, and solutions to NecstGen, and both organizations will share their [...]
Zetta Genomics gains £2.5m seed funding to realise the power of genomic data in precision medicine
February 1, 2022
Nina Capital, APEX Medical and Cambridge Enterprise invest in transformational open-source data technology – to deliver precision medicine at scale University of Cambridge technology spin-out Zetta Genomics announces that is has raised £2.5 million in new seed funding. The successful round secures leading global Venture Capital (VC) investment in the company’s XetaBase platform – a [...]
February 1, 2022
Cecilia Grotte takes up her position in Spring 2022 Swedish Software company Qlucore, listed on Nasdaq First North, today announces that it has appointed Cecilia Grotte with the intention to install her as CFO to take over from interim CFO Anders Bergstrand. Cecilia Grotte’s previous employment was as CFO at SimFAS Sweden. Her employment with [...]
Promega Earns a 2022 Top Workplaces USA Award
February 1, 2022
Biotech company recognized for culture supporting work-life balance Madison, WI USA. -- Promega Corporation was recognized today as a top place to work in the US with a 2022 Top Workplaces USA award. Companies earn a place on the Top Workplaces USA list based solely on employee engagement surveys compiled by research firm Energage. More [...]
Polyplus Acquires e-Zyvec to Expand Expertise in plasmid DNA Vector Engineering
February 1, 2022
Polyplus today announces the acquisition of E-Zyvec with a focus on expanding process economics optimization efforts for cell and gene therapy developers and manufacturers. Strasbourg, France – Polyplus, a leading provider of upstream process solutions for advanced biologic and cell and gene therapy production from research to commercial grade, today announces the acquisition of e-Zyvec, [...]
February 1, 2022
CHELMSFORD, Mass. -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has completed the previously announced sale of the company's Semiconductor Solutions Group business (or "automation business") to Thomas H. Lee Partners ("THL") for $3.0 billion in cash, subject to adjustments for working capital and other items. Proceeds from the sale, net of taxes, fees and adjustments, are [...]

